MS Reversed by Transplanted Immune Cells That Fight Epstein-Barr Virus
25th April 2022
Transplants of immune cells that target the Epstein-Barr virus have shown promise for treating multiple sclerosis in an early stage trial. Brain scans suggest the progression of the condition was reversed in some participants, but this needs to be confirmed by larger trials.